Kymera Therapeutics, Inc. (KYMR) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kymera Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.767 Good day, everyone. My name is Olivia and I will be your conference operator today. 00:00:04.767 -- 00:00:10.085 At this time, I would like to welcome you to the Chimera Therapeutics second quarter 00:00:10.085 -- 00:00:15.143 2025 results call. All lines have been placed on mute to prevent any 00:00:15.143 -- 00:00:20.628 background noise. After the speaker's remarks, there'll be a question and answer session. 00:00:20.628 -- 00:00:24.471 If you would like to ask a question during this time, and if you have joined via the 00:00:24.471 -- 00:00:29.676 webinar, please use the raise hand icon, which can be found at the bottom of your webinar 00:00:29.676 -- 00:00:34.760 application. If you have joined by phone, please dial star nine on your 00:00:34.760 -- 00:00:40.205 keypad to raise your hand. At this time, I would like to turn the call over to Bruce 00:00:40.205 -- 00:00:43.197 Jacobs, Chief Financial Officer. 00:00:43.197 -- 00:00:47.986 Good morning. I'm Bruce Jacobs, and I'm kicking off this in place of Justine Konigsberg, 00:00:47.986 -- 00:00:52.495 our head of IR, who is out today. Joining me this morning are Nella Manolfi, founder, 00:00:52.495 -- 00:00:56.697 president, and CEO, and Jared Golub, our chief medical officer. 00:00:56.697 -- 00:01:00.545 Following our prepared remarks, we'll open the call to questions from our publishing 00:01:00.545 -- 00:01:05.114 analysts. If you'd like to ask a question, please use the raised hand icon, which can 00:01:05.114 -- 00:01:07.419 be found at the bottom of your meeting window. 00:01:07.419 -- 00:01:11.106 And to help us move efficiently through the Q&A session, we ask that you're ready to 00:01:11.106 -- 00:01:15.194 unmute your line when called upon. In addition, we ask that yo...